Guanine Inc. is a groundbreaking biotechnology company based in Rensselaer, NY, specializing in mobile syndromic quantification of nucleic acid targets and protein biomarkers for diagnosing complex illnesses. Their breakthrough technology enables low-cost testing and digital output to clinical information systems and AI models, revolutionizing the field of syndromic testing.
With a focus on reducing time, cost, and mortality in diagnosing complex illnesses, Guanine's innovative products offer enhanced accuracy and precision in detecting critical inputs such as pathogens, drug resistance biomarkers, genes, antibodies, and more. Their low-cost mobile reader provides valuable data for AI diagnosis and treatment, making Guanine a game changer in the healthcare industry.
Generated from the website